EDN1 and pulmonary arterial hypertension: Emerging trends in investigation of the biological properties of ET-1 and relevance of this vasoactive protein to cardiopulmonary disorders are driven substantially by recognition that this molecule is a critical factor in pathogenesis of diseases such as pulmonary arterial hypertension (PAH) (Kylhammar and Radegran 2016).